APA (7th ed.) Citation

Tungsanga, S., Ibrahim, H., Ye, F., Ehindero, T., Lategan, I., Okpechi, I. G., & Bello, A. K. WCN25-2866 ASSOCIATIONS OF STATIN USE WITH REDUCING THE RISK OF ADVERSE CLINICAL OUTCOMES IN A COHORT OF PATIENTS RECEIVING KIDNEY REPLACEMENT THERAPY IN CANADA. Elsevier.

Chicago Style (17th ed.) Citation

Tungsanga, Somkanya, Halimat Ibrahim, Feng Ye, Toluwatise Ehindero, Irizelle Lategan, Ikechi G. Okpechi, and Aminu K. Bello. WCN25-2866 ASSOCIATIONS OF STATIN USE WITH REDUCING THE RISK OF ADVERSE CLINICAL OUTCOMES IN A COHORT OF PATIENTS RECEIVING KIDNEY REPLACEMENT THERAPY IN CANADA. Elsevier.

MLA (9th ed.) Citation

Tungsanga, Somkanya, et al. WCN25-2866 ASSOCIATIONS OF STATIN USE WITH REDUCING THE RISK OF ADVERSE CLINICAL OUTCOMES IN A COHORT OF PATIENTS RECEIVING KIDNEY REPLACEMENT THERAPY IN CANADA. Elsevier.